Highlights From Altria’s 4th-Quarter Earnings Call

MarketBusiness
Feb.08.2023
Company says smokers switching to cheaper options; gives update on innovation

Hannah Hammond of cspdailynews.com

 

High inflation rates in 2022 affected tobacco consumer’s behaviors, discretionary income and spending, Altria said in its fourth-quarter 2022 earnings report.

 

“As a result, our businesses and the industry experienced elevated volume declines, and we observed accelerated share growth in discount cigarettes,” the Richmond, Virginia-based tobacco company said. “Despite these factors, our leading tobacco brands remained resilient, and we continued to observe significant brand loyalty in the tobacco space overall.”

 

Net revenues decreased 2.3% to $6.1 billion in fourth quarter 2022, primarily driven by lower net revenues in the smokeable products segment, Altria said. For the full year 2022, net revenues were down 3.5% to $25.1 billion year-over-year. This was primarily driven by the sale of Altria’s former Ste. Michelle wine business in October 2021, the company said, and lower net revenues in the smokeable products segment.

 

Cigarette Sales Sink

 

Altria’s cigarette sales volume sunk by about 12% in the fourth quarter of 2022. The consumer remains under pressure, Altria’s CEO Billy Gifford said at the company’s Feb. 1 earnings call, which is causing them to smoke fewer cigarettes per day and switch to cheaper brands.

 

Marlboro’s, Altria’s flagship cigarette brand, retail share of the total cigarette category decreased 0.4 share points to 42.5% in the fourth quarter. This was primarily due to increased macroeconomic pressures on the adult tobacco consumer’s disposable income and increased competitive activity, Altria said.

 

However, Marlboro’s share of the premium segment grew to 58.2%, an increase of 0.5% share points.

 

“We are encouraged by Marlboro’s resilient performance as the brand celebrates 50 years of leadership in the cigarette category,” Sal Mancuso, Altria’s CFO, said on the call.

 

Nicotine Pouches Increase Share

 

The U.S. nicotine pouch category grew to 24.4% of the U.S. oral tobacco category in fourth quarter 2022, an increase from the year prior. Altria’s modern oral nicotine (MON) pouch On grew its share 2.5 points versus the prior year to 24%, Altria said. 

 

“This impressive performance was driven by continued increases in brand awareness and adoption by smokers and dippers,” Gifford said. “Additionally, we believe Helix effectively managed On promotional spend as the year progressed and reduced On promotional spend per can by approximately 15% during the second half of the year compared to the first half.”

 

 Altria established Helix Innovations LLC in 2019 to commercialize and distribute On.

 

Innovation Progresses

 

Gifford also highlighted the company’s progress in innovation.

 

“In oral tobacco product development, we are excited to announce we have finalized a new product design, which will provide tobacco consumers more smoke-free options within our portfolio,” he said. “We also began regulatory preparations for the product, and we are encouraged by the initial research results and the response we have received from dippers and nicotine pouch users.”

 

More information on the product will be released at Altria’s investor day in March, he said.

 

Altria has not finalized the design of its heated tobacco capsule product, but the team is making progress, Gifford said. It also announced a strategic partnership with Japan Tobacco in October to eventually bring heated tobacco sticks, made of Ploom-branded devices and Marlboro-branded consumables, to the United States.

 

Juul Devalued

 

E-vapor has been a major contributor to the growth of smoke-free products over the five-year period, Gifford said, although volumes declined by an estimated 1% year-over-year amid considerable regulatory uncertainty, such as the FDA marketing denial order and subsequent temporary stay on Juul products. This cause disruptions for both consumers and retailers, he said.

 

As of Dec. 31, 2022, the estimated fair value of Altria’s investment in Juul was $250 million. This is a significant drop from the initial value of Juul when Altria invested a 35% stake in the company in 2018.

 

In September, when Altria announced it was ending its noncompete agreement with Juul, San Francisco, it said it valued its investment in Juul at $450 million. Juul did not respond back to CSP’s request for comment on its devaluation.

*The content excerpted or reproduced in this article comes from a third-party, and the copyright belongs to the original media and author. If any infringement is found, please contact us to delete it. Any entity or individual wishing to forward the information, please contact the original author and refrain from forwarding directly from here.

U.S. Adult Smoking Rate Falls to Historic Single-Digit Low of 9.9%, Study Shows Shift in Nicotine Use Patterns
U.S. Adult Smoking Rate Falls to Historic Single-Digit Low of 9.9%, Study Shows Shift in Nicotine Use Patterns
A new study analyzing National Health Interview Survey data found that adult cigarette smoking in the United States declined to 9.9% in 2024, down from 10.8% in 2023. The findings, published in NEJM Evidence, represent a historic milestone in U.S. tobacco control efforts. Researchers noted that while cigarette smoking is decreasing, the prevalence of e-cigarette and cigar use remained largely unchanged, suggesting a shift in nicotine consumption rather than the elimination of tobacco use.
Market
Mar.20
Sesh Launches 200-Pouch Refill Bag, Expanding Retail Unit Size in U.S. Nicotine Pouch Market
Sesh Launches 200-Pouch Refill Bag, Expanding Retail Unit Size in U.S. Nicotine Pouch Market
According to a LinkedIn post published by Sesh CMO Josh Metz on February 25, 2026, Sesh Products has introduced a 200-pouch nicotine pouch refill bag sold with a reusable metal can. In a U.S. MO market dominated by 20-pouch plastic cans, the product offers a larger retail unit size. The company lists a standard price of USD 49.99, with a uniform 15% discount currently applied, bringing the price to USD 42.49.
Innovation
Feb.25
U.S. Military Smoking Debate Spotlights E-Cigarettes and Nicotine Pouches as a “Bridge”
U.S. Military Smoking Debate Spotlights E-Cigarettes and Nicotine Pouches as a “Bridge”
At a policy forum hosted by The Hill and sponsored by PMI US, U.S. defense health officials, lawmakers and industry representatives discussed tobacco use in the military and explored the potential role of smoke-free nicotine products — including e-cigarettes and nicotine pouches — as transitional tools to help service members reduce reliance on combustible cigarettes.
PMI
Mar.23
Exclusive|Logistics Operators Warn of Possible New U.S. Border Crackdown on Illicit Vapes
Exclusive|Logistics Operators Warn of Possible New U.S. Border Crackdown on Illicit Vapes
Recent inspections and cargo disruption have led some logistics operators in the China-U.S. vape trade to see early signs of another U.S. border crackdown on illicit e-cigarettes. With late April to early May viewed as a key risk window, the market is watching closely. The bigger question is not only whether enforcement will tighten, but whether it can be sustained.
Special Report
Apr.09
Special Report | Breeze and Glas Seek White House Review as FDA Advances Flavored ENDS Guidance
Special Report | Breeze and Glas Seek White House Review as FDA Advances Flavored ENDS Guidance
Breeze Smoke and Glas, Inc. have separately requested White House review under Executive Order 12866 as the FDA advances draft guidance on flavored ENDS (RIN 0910-ZC78). The guidance aims to clarify evidentiary standards under the statutory “appropriate for the protection of public health” (APPH) framework. The parallel filings highlight industry concern over regulatory predictability, particularly as Glas’s PMTA review status has recently drawn market attention.
Special Report
Mar.03
Special Report|Reynolds’ 337 Patent Case Ends, but a Harsher 337 Compliance Battle Now Targets the Entire Vape Supply Chain
Special Report|Reynolds’ 337 Patent Case Ends, but a Harsher 337 Compliance Battle Now Targets the Entire Vape Supply Chain
The U.S. International Trade Commission (ITC) has terminated Investigation 337-TA-1410 after invalidating key vape patent claims asserted by R.J. Reynolds Vapor Company, removing the immediate risk of import bans for dozens of companies. However, a new case—337-TA-1486—has already opened a more consequential legal front, shifting the focus from patent disputes to regulatory compliance across the vape supply chain, including PACT Act reporting, tax compliance, and FDA marketing authorization.
BAT
Mar.11